125 related articles for article (PubMed ID: 65215)
1. Immunological tumour profile: organ-specific carcinoma diagnosis in patients employing the macrophage electrophoretic mobility test.
Müller M; Irmscher J; Fischer R; Heidl G; Grossmann H
Cancer Lett; 1977 Jan; 2(3):139-45. PubMed ID: 65215
[TBL] [Abstract][Full Text] [Related]
2. Simplified cell microelectrophoretic method applied to the macrophage electrophoretic mobility test for cancer diagnosis.
Fike RM; van Oss CJ
Immunol Commun; 1979; 8(2):173-84. PubMed ID: 86499
[TBL] [Abstract][Full Text] [Related]
3. [Reaction of inhibition of macrophage electrophoretic mobility in differential diagnosis of carcinomas].
Miuller M; Irmsher Iu; Fisher R; Grosmann G
Vopr Onkol; 1976; 22(12):43-50. PubMed ID: 1020256
[TBL] [Abstract][Full Text] [Related]
4. [Experiences with the macrophage electrophoresis mobility test (MEM test) in the diagnosis of malignant gynecological diseases].
Günther J
Zentralbl Bakteriol Orig B; 1975; 91(9):529-39. PubMed ID: 52961
[TBL] [Abstract][Full Text] [Related]
5. The macrophage electrophoretic mobility test: Results on carcinoma of the colon and rectum.
Glaves D; Harlos JP; Weiss L
Int J Cancer; 1977 Apr; 19(4):474-81. PubMed ID: 66210
[TBL] [Abstract][Full Text] [Related]
6. Comparison between the macrophage electrophoretic mobility (MEM) and the fixed tanned erythrocyte electrophoretic mobility (FTEEM) tests in the detection of cancer.
Harlos JP; Weiss L
Int J Cancer; 1978 Apr; 21(4):413-7. PubMed ID: 78907
[TBL] [Abstract][Full Text] [Related]
7. Failure to obtain positive MEM tests in either cell-mediated immune conditions in the guinea-pig or in human cancer.
Arvilommi H; Dale MM; Desai HN; Mongar JL; Richardson M
Br J Cancer; 1977 Nov; 36(5):545-9. PubMed ID: 588418
[TBL] [Abstract][Full Text] [Related]
8. Reactivity in the MEM-test of cancer patients' lymphocytes incubated with brain-derived preparations and extracts from malignant teratomas.
Müller M; Irmscher J; Grossmann H; Kotzsch M; Wagner H; Kemmer C
Arch Geschwulstforsch; 1981; 51(4):354-63. PubMed ID: 6172087
[TBL] [Abstract][Full Text] [Related]
9. The macrophage electrophoretic mobility (MEM) test for malignant disease. Further clinical investigations and studies on macrophage slowing factors.
Preece AW; Light PA
Clin Exp Immunol; 1974 Dec; 18(4):543-52. PubMed ID: 4143199
[TBL] [Abstract][Full Text] [Related]
10. Evaluation and development of the macrophage electrophoretic mobility (MEM) test for malignant disease.
Pritchard JA; Moore JL; Sutherland WH; Joslin CA
Br J Cancer; 1973 Jan; 27(1):1-9. PubMed ID: 4686176
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of macrophage electrophoretic mobility (MEM) test as an indicator of cellular immunity in ocular tumours.
Rahi AH; Otiko G; Winder AF
Br J Ophthalmol; 1976 Aug; 60(8):589-93. PubMed ID: 61762
[TBL] [Abstract][Full Text] [Related]
12. An assessment of the macrophage electrophoretic mobility test (MEM) in cancer diagnosis.
Crozier EH; Hollinger ME; Woodend BE; Robertson JH
J Clin Pathol; 1976 Jul; 29(7):608-9. PubMed ID: 988059
[TBL] [Abstract][Full Text] [Related]
13. Biological and clinical significance of macrophage electrophoretic mobility (MEM) test in tumor immunity.
Nakajima T; Isojima K; Iwaguchi T
Cell Mol Biol Incl Cyto Enzymol; 1979; 25(5):355-61. PubMed ID: 394842
[No Abstract] [Full Text] [Related]
14. Macrophage electrophoretic mobility (MEM) test in cancer: a critical evaluation.
Field EJ; Caspary EA; Smith KS
Br J Cancer Suppl; 1973 Aug; 1():208-14. PubMed ID: 4140728
[TBL] [Abstract][Full Text] [Related]
15. The use of the macrophage electrophoretic mobility test for the diagnosis of eye diseases.
Jenssen R; Jenssen HL; Köhler H; Friemel H
Mod Probl Ophthalmol; 1976; 16():259-64. PubMed ID: 943037
[TBL] [Abstract][Full Text] [Related]
16. [Cross-reactivity of 3M KCl extracts of fetal tissue from various species in the macrophage electrophoresis mobility (MEM) test. I. Extracts from fetuses of mammals and one species of fowl].
Schlott B; Gryschek G; Reinhöfer J; von Broen B; Pasternak G
Arch Geschwulstforsch; 1983; 53(2):93-8. PubMed ID: 6344836
[TBL] [Abstract][Full Text] [Related]
17. Immunodiagnostics of malignant disease. VI. Electrophoretic mobility test (EMT) in malignant melanoma.
Douwes FR; Spellmann HJ; Mross K; Wolfrum DI
Oncology; 1978; 35(4):163-7. PubMed ID: 81476
[TBL] [Abstract][Full Text] [Related]
18. Lymphocyte sensitization detected in lymphomatous hamadryas baboons by the macrophage electrophoretic mobility assay.
Malkovský M; Bubeník J; Indzhiya LV; Lapin BA; Yakovleva LA
Folia Biol (Praha); 1980; 26(1):70-3. PubMed ID: 6244991
[TBL] [Abstract][Full Text] [Related]
19. Regulation of autosensitisation to encephalitogenic myelin basic protein by macrophage-association and soluble antigen.
Steinman L; Cohen IR; Teitelbaum D; Arnon R
Nature; 1977 Jan; 265(5590):173-5. PubMed ID: 64932
[No Abstract] [Full Text] [Related]
20. A reappraisal of the macrophage electrophoretic mobility (MEM) test for the measurement of lymphokine activity.
Brown KA; Wolstencroft RA; Booth CG; Dumonde DC
J Immunol Methods; 1985 Oct; 82(2):189-98. PubMed ID: 3900214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]